Loading...
•
Dec 31, 2024
Alcon Q4 2024 Earnings Report
Alcon reported strong sales growth, increased earnings, and improved margins in Q4 2024.
Key Takeaways
Alcon achieved net sales of $2.5 billion in Q4 2024, a 6% increase over the previous year. Operating income rose significantly to $395 million, with an operating margin expansion of 7 percentage points. The company reported diluted EPS of $0.57 and core diluted EPS of $0.72.
Net sales grew 6% to $2.5 billion in Q4 2024.
Operating income increased to $395 million, driven by higher sales and improved margins.
Diluted EPS was $0.57, while core diluted EPS increased to $0.72.
Vision Care net sales saw strong growth of 8% to $1.1 billion.
Alcon
Alcon
Alcon Revenue by Segment
Alcon Revenue by Geographic Location
Revenue by Segment
Total Surgical Revenue
CapyFin.comTotal Vision Care Revenue
CapyFin.comRevenue by Geographic Location
United States Revenue
CapyFin.comInternational Revenue
CapyFin.com Forward Guidance
Alcon expects continued growth in 2025 with a focus on innovation and operating leverage to drive earnings.
Positive Outlook
- Projected net sales growth of 6% to 8%.
- Core diluted EPS expected between $3.15 to $3.25.
- Core operating margin forecasted at 21% to 22%.
- Ongoing investments in R&D for product innovation.
- Focus on driving long-term shareholder value.
Challenges Ahead
- Potential headwinds from foreign exchange rates.
- Expected cost pressures from raw materials.
- Increased investment in marketing initiatives.
- Rising labor costs could impact profitability.
- Uncertainty in global economic conditions.
Revenue & Expenses
Visualization of income flow from segment revenue to net income